| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000226007.2 |
ABT-263 (navitoclax) |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043750419 |
Sensitive |
| ENSG00000226007.2 |
ABT-263 (navitoclax) |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014713559 |
Sensitive |
| ENSG00000226007.2 |
ABT-263 (navitoclax) |
Sarcoma |
0.029762171 |
Sensitive |
